Next-generation sequencing market is projected to be worth USD 19 billion

Roots Analysis has announced the addition of "Next Generation Sequencing (NGS) Market, 2020-2030" report to its list of offerings.
By: Roots Analysis
 
COLLIER, Alaska - March 26, 2020 - PRLog -- The genome sequencing domain has witnessed a surge in the availability of service providers, With gene sequencing costs having come down by several orders of magnitude, a number of players have expended significant resources in building elaborate service portfolios to cater to the needs within the biotech and life sciences industries.

Roots Analysis has announced the addition of "Next Generation Sequencing (NGS) Market, 2020-2030 (https://www.rootsanalysis.com/reports/view_document/next-generation-sequencing/290.html)" report to its list of offerings.

At present, industry stakeholders are actively collaborating in order to integrate their respective resources for mining large and complex datasets to generate clinically relevant, actionable insights. Ongoing innovation in this domain, coupled to the increasing demand for genome data, is expected to bring a paradigm shift in the fields of drug discovery, biomarker research and companion diagnostics, and personalized medicine.

To order this 270+ page report, which features 120+ figures and 150+ tables, please visit this link

Key Market Insights

Over 120 industry and non-industry players claim to offer next generation sequencing services
Companies engaged in this domain are known to primarily use second and third generation technologies for whole genome, whole exome and targeted sequencing.

Over 2,600 registered clinical trials (till September 2019) involved the use of gene sequence data
Close to 80% of these trials were sponsored by non-industry players, which were focused on the development of both drug products and diagnostic solutions.

5,200+ patents related to genome sequencing have been filed in the last four years alone
Close to 55% of the patents were filed in North America, with applications primarily focused on biomarker discovery, for use across a variety of cancer indications. The primary focus of majority of the patents is on cancer treatment and biomarker discovery.

To request a sample copy / brochure of this report, please visit this link

The USD 19 billion (by 2030) financial opportunity within the next generation sequencing market has been analyzed across the following segments:

• Type of Offering

• Products
• Services

The report features inputs from eminent industry stakeholders, according to whom next generation technologies have already revolutionized the way genomes are sequenced, and demonstrated significant cost saving potential. It includes detailed transcripts of discussions held with senior industry stakeholders.

For additional details, please visit https://www.rootsanalysis.com/reports/view_document/next-... or email sales@rootsanalysis.com

Contact:

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com

Contact
Roots Analysis
***@gmail.com
End
Source:Roots Analysis
Email:***@gmail.com
Tags:Research
Industry:Biotech
Location:Collier - Alaska - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
nnn PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share